NFKB1 and Miyoshi myopathy: Mechnistic studies demonstrate that PIRH2 reduces phosphorylated IκBα (pIκBα) levels and IκB kinase α (IKKα) expression, subsequent inhibiting the canonical NF-κB signaling pathway in MM cells (Yang et al., 2018).